Last reviewed · How we verify
oral vancomycin and oral amoxicillin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
oral vancomycin and oral amoxicillin (oral vancomycin and oral amoxicillin) — University of Minnesota.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| oral vancomycin and oral amoxicillin TARGET | oral vancomycin and oral amoxicillin | University of Minnesota | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- oral vancomycin and oral amoxicillin CI watch — RSS
- oral vancomycin and oral amoxicillin CI watch — Atom
- oral vancomycin and oral amoxicillin CI watch — JSON
- oral vancomycin and oral amoxicillin alone — RSS
Cite this brief
Drug Landscape (2026). oral vancomycin and oral amoxicillin — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-vancomycin-and-oral-amoxicillin. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab